Belpointe Asset Management LLC Lowers Holdings in GE HealthCare Technologies Inc. $GEHC

Belpointe Asset Management LLC trimmed its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 32.6% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 17,967 shares of the company’s stock after selling 8,695 shares during the period. Belpointe Asset Management LLC’s holdings in GE HealthCare Technologies were worth $1,450,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. N.E.W. Advisory Services LLC purchased a new position in GE HealthCare Technologies in the first quarter worth approximately $25,000. Bogart Wealth LLC grew its position in GE HealthCare Technologies by 260.0% in the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock worth $28,000 after acquiring an additional 247 shares during the period. Stonebridge Financial Group LLC grew its position in GE HealthCare Technologies by 165.7% in the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company’s stock worth $29,000 after acquiring an additional 222 shares during the period. Ameriflex Group Inc. purchased a new position in GE HealthCare Technologies in the fourth quarter worth approximately $31,000. Finally, Olde Wealth Management LLC purchased a new position in GE HealthCare Technologies in the first quarter worth approximately $35,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 2.6%

NASDAQ:GEHC opened at $77.96 on Friday. The firm has a market cap of $35.59 billion, a PE ratio of 15.98, a price-to-earnings-growth ratio of 2.90 and a beta of 1.13. The stock has a fifty day moving average price of $74.45 and a 200 day moving average price of $73.76. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.15. The firm had revenue of $5 billion during the quarter, compared to analyst estimates of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.GE HealthCare Technologies’s revenue was up 3.5% compared to the same quarter last year. During the same period last year, the business posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were issued a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 2.87%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on GEHC shares. Wall Street Zen upgraded GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 31st. Zacks Research upgraded GE HealthCare Technologies from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 28th. Citigroup raised their price target on GE HealthCare Technologies from $89.00 to $93.00 and gave the stock a “buy” rating in a research report on Thursday, July 31st. BTIG Research restated a “buy” rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Finally, Morgan Stanley lowered their price target on GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating for the company in a research report on Thursday, July 31st. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $88.40.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.